Remy Durand - 21 Apr 2023 Form 3 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Role
Chief Business Officer
Signature
/s/ James Paul Rickey, attorney-in-fact
Issuer symbol
N/A
Transactions as of
21 Apr 2023
Net transactions value
$0
Form type
3
Filing time
27 Apr 2023, 15:58:14 UTC
Next filing
05 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALPN Common Stock 6,904 21 Apr 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALPN Stock Option (Right to buy) 21 Apr 2023 Common Stock 10,000 $4.76 Direct F1
holding ALPN Stock Option (Right to buy) 21 Apr 2023 Common Stock 25,000 $6.51 Direct F2
holding ALPN Stock Option (Right to buy) 21 Apr 2023 Common Stock 15,000 $4.09 Direct F3
holding ALPN Stock Option (Right to buy) 21 Apr 2023 Common Stock 65,000 $3.23 Direct F4
holding ALPN Stock Option (Right to buy) 21 Apr 2023 Common Stock 80,000 $13.20 Direct F5
holding ALPN Stock Option (Right to buy) 21 Apr 2023 Common Stock 112,500 $13.30 Direct F6
holding ALPN Stock Option (Right to buy) 21 Apr 2023 Common Stock 109,000 $7.55 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4) of the shares subject to the option will vest on October 8, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to be a service provider through each such date.
F2 One-fourth (1/4) of the shares subject to the option will vest on February 6, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to be a service provider through each such date.
F3 One-fourth (1/4) of the shares subject to the option will vest on May 1, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to be a service provider through each such date.
F4 One-fourth (1/4) of the shares subject to the option will vest on January 23, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to be a service provider through each such date.
F5 One-fourth (1/4) of the shares subject to the option will vest on January 5, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to be a service provider through each such date.
F6 One-fourth (1/4) of the shares subject to the option will vest on January 4, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to be a service provider through each such date.
F7 One-fourth (1/4) of the shares subject to the option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to be a service provider through each such date.

Remarks:

Ex. 24 Power of Attorney